The University of Maryland Medical System (UMMS) Pharmacy and Therapeutics (P&T) Committee is an interdisciplinary committee that is charged with developing and maintaining the UMMS shared formulary based on clinical evidence, safety, and efficacy. The goals and objectives of the System P&T Committee are to improve outcomes, quality, patient safety, and efficiency of the medications used within the UMMS in a cost-conscious manner. The System P&T Committee makes formulary decisions for all facilities within the UMMS and reports directly to the Chief Medical Office (CMO) Council and Operational Performance Improvement Group.

Contact Us

Megan G. Anders, MD, MS
Assistant Professor of Anesthesiology
Associate Chair for Safety and Quality
Department of Anesthesiology
University of Maryland School of Medicine
Co-Chair, System P&T Committee 
MAnders@som.umaryland.edu

Fermin Barrueto Jr., MD, MBA
Senior Vice President of Medical Affairs and Chief Medical Officer
University of Maryland Upper Chesapeake Health
Co-Chair, System P&T Committee
FBarrueto@umm.edu 

Mary Ghaffari, PharmD, BCPS
Director, UMMS Clinical Pharmacy Services
University of Maryland Medical System
Co-Chair, System P&T Committee
Mary.Ghaffari@umm.edu

Laura Heath, PharmD, BCCCP

Clinical Pharmacy Specialist, System Formulary Management
University of Maryland Medical System
Laura.Heath@umm.edu

Farrah Tavakoli, PharmD, BCPS
Clinical Pharmacy Specialist, System Formulary Management
University of Maryland Medical System
Farrah.Tavakoli@umm.edu

Pharmacy Documents and Guidelines

UMMS COVID-19 Updates:

UMMS Documents: 

UMMS Guidelines:

This content is for Internal Use only.